CCR2/5 receptor antagonist (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCR2/5 receptor antagonist (investigational), covering 2015-10-21 to 2015-10-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy [Phase 2]